E
Rallybio Corporation RLYB
$0.626 $0.0325.39% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 40.24% 50.40% 45.44% 37.60% 12.85%
Total Depreciation and Amortization -23.53% -20.00% -16.67% -13.51% -10.53%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -11.98% 0.98% -17.09% -9.93% -4.29%
Change in Net Operating Assets -111.85% -334.08% -115.27% -521.88% 21.23%
Cash from Operations 19.57% 33.98% 15.31% 17.76% 22.16%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 16.91% 7.96% -109.30% 623.29% -58.22%
Cash from Investing 16.91% 7.96% -109.30% 623.29% -58.22%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.82% -- -75.34% -- 2,507.18%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% -- -25,800.00%
Cash from Financing -99.81% -- -75.00% -- 2,372.38%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -102.81% 116.87% -313.96% 164.54% 62.21%